Characterization of cerebral microbleeds in idiopathic Parkinson's disease

J-H Kim1, J Park, Y-H Kim

  • 1Department of Neurology, Keyo Medical Foundation, Keyo Geriatric Hospital, Uiwang, Korea.

Abstract

Insights

Cerebral microbleeds (CMBs) are present in idiopathic Parkinson's disease (IPD) but are distinct from vascular parkinsonism (VP). CMBs in IPD do not significantly impact cognition but differ in number and location from VP.

Area of Science:

  • Neurology
  • Neuroimaging
  • Neurodegenerative Diseases

Background:

  • Cerebral microbleeds (CMBs) are studied in various neurological conditions.
  • Their role in idiopathic Parkinson's disease (IPD) requires further characterization.

Purpose of the Study:

  • To define the clinical and radiological features of CMBs in IPD.
  • To differentiate CMBs in IPD from those in vascular parkinsonism (VP).

Main Methods:

  • Cross-sectional study of parkinsonian patients.
  • Standard MRI with gradient recalled echo at 3 T.

Main Results:

  • CMBs were less common in IPD (17.7%) than VP (56%).
  • In IPD, CMBs correlated with white matter hyperintensities and lacunar infarctions but not cognitive decline.
  • CMBs in IPD differed in number and topography compared to VP.

Conclusions:

  • CMBs are not uncommon in IPD and are distinct from VP.
  • IPD with CMBs does not appear to be a variant of VP.
  • Further research is needed on the clinical significance of CMBs in IPD prognosis and cognition.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
11
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
6
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.5K
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
7